U.S. Markets close in 6 hrs 15 mins

Beyond Air, Inc. (XAIR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
7.85-0.04 (-0.51%)
As of 09:38AM EDT. Market open.

Beyond Air, Inc.

900 Stewart Avenue
Suite 301
Garden City, NY 11530
United States
516 665 8200

IndustryMedical Devices
Full Time Employees62

Key Executives

NameTitlePayExercisedYear Born
Mr. Steven Adam LisiCEO & Chairman450kN/A1971
Mr. Amir AvnielCo-Founder, Pres & Chief Bus. Officer400kN/A1974
Mr. Douglas Quinton LarsonCFO, Principal Financial Officer & Principal Accounting Officer274.95kN/A1971
Mr. Michael A. GaulChief Operating OfficerN/AN/A1955
Ms. Maria YonkoskiHead of Investor RelationsN/AN/AN/A
Mr. Adam NewmanChief Legal Officer & Gen. CounselN/AN/AN/A
Ms. Rebecca Van DorenHead of SalesN/AN/AN/A
Ms. Kori-Ann TaylorHead of MarketingN/AN/AN/A
Prof. Andrew R. Colin M.D.Chief Medical Officer & Member of Scientific Advisory BoardN/AN/AN/A
Dr. Giora Davidai M.D.Chief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Corporate Governance

Beyond Air, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.